Resultados de búsqueda - Young, Jim
- Mostrando 1 - 20 Resultados de 21
- Ir a la Siguiente Página
-
1
-
2
-
3
-
4
George Geoffrey Worsp por Giles, Alan, Young, Jim, Cousins, David
Publicado 2008Texto -
5
Comparison of single-dose and multiple-dose pharmacokinetics between two formulations of hydrocodone bitartrate/acetaminophen: immediate-release versus biphasic immediate-release/e... por Devarakonda, Krishna, Kostenbader, Kenneth, Giuliani, Michael J, Young, Jim L
Publicado 2015Texto -
6
-
7
Patterns of practice and barriers to care for hepatitis C in the direct-acting antiviral (DAA) era: A national survey of Canadian infectious diseases physicians por Chan, Justin, Young, Jim, Cox, Joseph, Nitulescu, Roy, Klein, Marina B
Publicado 2018Texto -
8
Variation between Canadian centres in the uptake of treatment for hepatitis C by patients coinfected with HIV: a prospective cohort study por Young, Jim, Potter, Martin, Cox, Joseph, Cooper, Curtis, Gill, John, Hull, Mark, Walmsley, Sharon, Klein, Marina B.
Publicado 2013Texto -
9
Procalcitonin-guided antibiotic use versus a standard approach for acute respiratory tract infections in primary care: study protocol for a randomised controlled trial and baseline... por Briel, Matthias, Christ-Crain, Mirjam, Young, Jim, Schuetz, Philipp, Huber, Peter, Périat, Pierre, Bucher, Heiner C, Müller, Beat
Publicado 2005Texto -
10
Pretreatment CD4 Cell Slope and Progression to AIDS or Death in HIV-Infected Patients Initiating Antiretroviral Therapy—The CASCADE Collaboration: A Collaboration of 23 Cohort Stud... por Wolbers, Marcel, Babiker, Abdel, Sabin, Caroline, Young, Jim, Dorrucci, Maria, Chêne, Geneviève, Mussini, Cristina, Porter, Kholoud, Bucher, Heiner C.
Publicado 2010Texto -
11
Favourable IFNL3 Genotypes Are Associated with Spontaneous Clearance and Are Differentially Distributed in Aboriginals in Canadian HIV-Hepatitis C Co-Infected Individuals por Moqueet, Nasheed, Infante-Rivard, Claire, Platt, Robert W., Young, Jim, Cooper, Curtis, Hull, Mark, Walmsley, Sharon, Klein, Marina B.
Publicado 2015Texto -
12
Direct-Acting Antiviral Treatment Failure Among Hepatitis C and HIV–Coinfected Patients in Clinical Care por Rossi, Carmine, Young, Jim, Martel-Laferrière, Valérie, Walmsley, Sharon, Cooper, Curtis, Wong, Alexander, Gill, M John, Klein, Marina B
Publicado 2019Texto -
13
Transient detectable viremia and the risk of viral rebound in patients from the Swiss HIV Cohort Study por Young, Jim, Rickenbach, Martin, Calmy, Alexandra, Bernasconi, Enos, Staehelin, Cornelia, Schmid, Patrick, Cavassini, Matthias, Battegay, Manuel, Günthard, Huldrych F., Bucher, Heiner C.
Publicado 2015Texto -
14
Liver Fibrosis in Human Immunodeficiency Virus (HIV)-Hepatitis C Virus (HCV) Coinfection Before and After Sustained Virologic Response: What Is the Best Noninvasive Marker for Moni... por Kronfli, Nadine, Young, Jim, Wang, Shouao, Cox, Joseph, Walmsley, Sharon, Hull, Mark, Cooper, Curtis, Martel-Laferriere, Valerie, Wong, Alexander, Pick, Neora, Klein, Marina B
Publicado 2020Texto -
15
Risk Factors for Hepatitis C Virus Reinfection After Sustained Virologic Response in Patients Coinfected With HIV por Young, Jim, Rossi, Carmine, Gill, John, Walmsley, Sharon, Cooper, Curtis, Cox, Joseph, Martel-Laferriere, Valerie, Conway, Brian, Pick, Neora, Vachon, Marie-Louise, Klein, Marina B.
Publicado 2017Texto -
16
Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study por Young, Jim, De Geest, Sabina, Spirig, Rebecca, Flepp, Markus, Rickenbach, Martin, Furrer, Hansjakob, Bernasconi, Enos, Hirschel, Bernard, Telenti, Amalio, Vernazza, Pietro, Battegay, Manuel, Bucher, Heiner C
Publicado 2004Texto -
17
The effectiveness of daclatasvir based therapy in European patients with chronic hepatitis C and advanced liver disease por Young, Jim, Weis, Nina, Hofer, Harald, Irving, William, Weiland, Ola, Giostra, Emiliano, Pascasio, Juan Manuel, Castells, Lluis, Prieto, Martin, Postema, Roelien, Lefevre, Cinira, Evans, David, Bucher, Heiner C., Calleja, Jose Luis
Publicado 2017Texto -
18
Factors associated with syphilis incidence in the HIV-infected in the era of highly active antiretrovirals por Shilaih, Mohaned, Marzel, Alex, Braun, Dominique L., Scherrer, Alexandra U., Kovari, Helen, Young, Jim, Calmy, Alexandra, Darling, Katharine, Battegay, Manuel, Hoffmann, Matthias, Bernasconi, Enos, Thurnheer, Maria C., Günthard, Huldrych F., Kouyos, Roger D.
Publicado 2017Texto -
19
Disparities in direct acting antivirals uptake in HIV‐hepatitis C co‐infected populations in Canada por Saeed, Sahar, Strumpf, Erin C, Moodie, Erica EM, Young, Jim, Nitulescu, Roy, Cox, Joseph, Wong, Alexander, Walmsely, Sharon, Cooper, Curtis, Vachon, Marie‐Lousie, Martel‐Laferriere, Valerie, Hull, Mark, Conway, Brian, Klein, Marina B
Publicado 2017Texto -
20
Do contemporary antiretrovirals increase the risk of end-stage liver disease? Signals from patients starting therapy in the NA-ACCORD por Young, Jim, Re, Vincent Lo, Kim, H. Nina, Sterling, Timothy R., Althoff, Keri N., Gebo, Kelly A., Gill, M. John, Horberg, Michael A., Mayor, Angel M., Moore, Richard D., Silverberg, Michael J., Klein, Marina B.
Publicado 2022Texto